Kurata Lance 4
4 · Arcturus Therapeutics Holdings Inc. · Filed Jun 23, 2022
Insider Transaction Report
Form 4
Kurata Lance
Chief Legal Officer
Transactions
- Award
Employee Stock Option (right to buy)
2022-06-21+50,000→ 50,000 totalExercise: $34.57Exp: 2031-12-10→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]Represents options to purchase shares of common stock conditionally approved by the Board of Directors on December 10, 2021, subject to approval of an amendment to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan by the Company's stockholders, which approval was obtained at the Company's 2022 Annual Meeting of Stockholders held on June 21, 2022.
- [F2]The shares underlying this option vest 25% on December 10, 2022, the first anniversary of the date this award was conditionally approved by the Board of Directors, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months.